Chemours offers asymmetric turnaround upside from Opteon, AI cooling, and deleveraging, but 4.4x leverage, PFAS liabilities, and near-term refrigerant destocking keep the risk high.
Overview
Chemours is a global specialty-chemicals company spun off from DuPont in 2015, serving approximately 2,400 customers in 110 countries through Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. Its Opteon, Ti-Pure, Teflon, Nafion, Viton, and Krytox brands support essential applications in refrigeration, coatings, automotive, semiconductors, hydrogen, and data centers. The company has defensible technology and regulatory positioning, but its recent financial trajectory is weak: FY2021–FY2025 sales declined at a -1.75% CAGR, adjusted EBITDA fell from $1.313 billion to $742 million, and margins compressed from 20.7% to 12.8%. Q2 2026 sales were $1.591 billion, below consensus of approximately $1.65–$1.66 billion, while adjusted EBITDA declined 5% to $247 million. **The near-term story is a refrigerant-channel destocking and leverage problem**, with 2026 EBITDA guidance reduced to $775–$825 million and net leverage at 4.4x. **The long-term upside rests on Opteon adoption, AI data-center cooling, and deleveraging.** At a reported $15.85, forward P/E is 14.0x on FY2026 adjusted EPS and 7.4x on FY2027 estimates, creating substantial recovery potential if normalization occurs.